pan>)--VasoStitch,
a start-up medical technology company, announced today that it has
successfully completed its first in vivo study of its
percutaneous access-and-closure system for the nonsurgical
deployment of large-diameter transcatheter therapeutic devices, such as
Transcatheter Aortic Valve Implants (TAVI) and Endovascular Aneurysm
Repair (EVAR) devices. The VasoStitch system is designed to reduce
procedural complexity and eliminate the need for an open surgical
procedure.
“We now look
forward to our First-in-Human milestone.”
The challenge with percutaneous catheter-based cardiac procedures is
that a surgical cut-down is required for access and then closure.
VasoStitch has developed two platform technologies designed to access
and close percutaneous therapy sites without the need for open surgery,
thus making catheter-based interventions simpler and more accessible.
Current surgical means of arterial or cardiac access and closure for
large diameter catheter-based interventions adds about an hour to an
already long and complex procedure. A device that can replicate the
current gold standard of surgical access and repair in a more rapid
and facile fashion will reduce healthcare costs dramatically, enhance
adoption of large-diameter cardiovascular and endovascular therapies,
and improve the efficiency of patient management, said David
W. J. Smith, President and CEO of VasoStitch. We now look
forward to our First-in-Human milestone.
VasoStitch was founded by Amir Belson, MD. Dr. Belson previously
founded NeoGuide Systems, a company that developed platform
technology for minimally invasive surgical procedures and was acquired
by Intuitive Surgical in 2009; more recently, Dr. Belson also has
founded Emboline, Vascular Pathways and ZipLine Medical.
About VasoStitch
VasoStitch
is an emerging medical device company that is developing nonsurgical
transfemoral and transapical access-and-closure systems to
facilitate deployment of large-diameter transcatheter therapeutic
devicesdesigned to reduce procedural complexity and eliminate the need
for an open surgical procedure.

Information Source: Business Wire